BACKGROUND: Controversies exist about the most appropriate management for patients
with incidental prostate cancer after surgery for benign prostatic hyperplasia (BPH) …

Study Type–Therapy (outcomes research) Level of Evidence 2b What's known on the
subject? and What does the study add? In the current literature, cT3 stage, biopsy Gleason> …

Purpose: We updated a long-term cancer control outcome in a large anatomical radical
retropubic prostatectomy (RRP) series. We also evaluated the perioperative parameters that …

OBJECTIVE To assess progression and survival among patients with small‐volume, well‐
differentiated, organ‐confined prostate cancer found at radical retropubic prostatectomy …

Objectives: This study was undertaken to distinguish between patients who will and will not
benefit from a retropubic radical prostatectomy (RRP) for clinically localized prostatic …

Objectives: To report oncological outcomes including biochemical recurrence (BR) following
radical prostatectomy (RP) from a large consecutive cohort operated in an 18-year period …

Abstract Objective: 10-30% of patients with T (1)/T (2) prostate cancer submitted to radical
prostatectomy ultimately fail. It may be important to detect failure as early as possible in …

Objective To identify risk factors of biochemical recurrence after radical prostatectomy in
high‐risk patients. Methods A total of 191 high‐risk prostate cancer patients according to the …

PURPOSE: We evaluated patients at our institution who underwent radical prostatectomy for
clinical stage T3 prostate cancer to determine their long-term clinical outcomes. MATERIALS …

OBJECTIVE: To estimate the effect of predictive factors for oncologic outcomes after radical
prostatectomy (RP) for high-risk prostate cancer (PCa). METHODS: A total of 813 patients …